Biggest News Aggregation in the World
📰 Increased Risk News

Page 3 - Increased Risk News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Increased Risk. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

GSK's RSV vaccine for adults 50-59 at increased risk accepted by FDA for Priority Review

GSK plc's application to extend its RSV vaccine indication to adults aged 50-59 at risk has been accepted by the FDA for priority review. If approved, it would be the first vaccine for this population. The application is supported by positive phase III trial results.
Clin Virol Richard Osei Yeboah Drug Administration Centers For Disease Prescription Drug User Fee Act Priority Review Voucher

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science